Details for New Drug Application (NDA): 202860

✉ Email this page to a colleague

NDA 202860 describes GENOSYL, which is a drug marketed by Vero Biotech Inc and is included in one NDA. It is available from one supplier. There are twenty-four patents protecting this drug. Additional details are available on the GENOSYL profile page.

The generic ingredient in GENOSYL is nitric oxide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nitric oxide profile page.

Summary for 202860

Tradename:	GENOSYL
Applicant:	Vero Biotech Inc
Ingredient:	nitric oxide
Patents:	24

Pharmacology for NDA: 202860

Physiological Effect	Vasodilation

Medical Subject Heading (MeSH) Categories for 202860

Bronchodilator Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Gasotransmitters
Neurotransmitter Agents

Suppliers and Packaging for NDA: 202860

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GENOSYL	nitric oxide	GAS;INHALATION	202860	NDA	VERO BIOTECH, INC.	72385-001	72385-001-01	216 L in 1 CARTRIDGE (72385-001-01)
GENOSYL	nitric oxide	GAS;INHALATION	202860	NDA	VERO BIOTECH, INC.	72385-002	72385-002-01	216 L in 1 CARTRIDGE (72385-002-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GAS;INHALATION			Strength	800PPM
Approval Date:	Dec 20, 2019	TE:		RLD:	Yes
Patent:	10,124,142	Patent Expiration:	Aug 18, 2025	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Patent:	10,213,572	Patent Expiration:	Feb 12, 2036	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	10,737,051	Patent Expiration:	Oct 20, 2035	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 202860

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Vero Biotech Inc	GENOSYL	nitric oxide	GAS;INHALATION	202860-001	Dec 20, 2019	6,758,214	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.